Recent Posts
- EA5231: A Randomized Phase III Trial of Checkpoint blockade in Lung cancEr patients in the Adjuvant setting based on pathologic Response following neoadjuvant therapy (CLEAR) (NCT06732401)
- BE6A Lung-02 (C5751003)
- A092205: Randomized Phase III Trial of Pembrolizumab vs. Pembrolizumab/Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Platinum Refractory Disease (NCT06589804)
- A032201: Short TeRm Intensified Pembrolizumab (KEytruda) and Tivozanib for High-risk renal cell carcinoma – STRIKE (NCT06661720)
- GOG3115/M25-231
Recent Comments
No comments to show.
